Trial intelligence / Profile preview

Myfortic in early corticosteroid withdrawal for renal transplant

NCT00374803Phase 4Completed

Sponsor
University of Cincinnati
Start
Apr 2006
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mycophenolate sodium in end stage renal disease (ESRD), sponsored by University of Cincinnati. Started Apr 2006; status: completed.

02

Drugs

mycophenolate sodium
03

Conditions

end stage renal disease (ESRD)

Beyond the preview

Go deeper on NCT00374803.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00374803.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call